SARS-Coronavirus Nucleocapsid Protein (SARS-CoV N) anticorps

N° du produit ABIN6952555

Cet anticorps Souris Monoclonal détecte spécifiquement dans ELISA, WB et IF. Il présente une réactivité envers SARS Coronavirus (SARS-CoV).

Aperçu rapide pour SARS-Coronavirus Nucleocapsid Protein (SARS-CoV N) anticorps (ABIN6952555)

Antigène: SARS-Coronavirus Nucleocapsid Protein (SARS-CoV N)

Reactivité: SARS Coronavirus (SARS-CoV)

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Inconjugué

Application: ELISA, Western Blotting (WB), Immunofluorescence (IF)

Clone: M88095

Détail du produit

Fonction: Mouse monoclonal SARS Coronavirus antibody

Specificité: This antibody recognizes the nucleoprotein of the SARS virus

Purification: Protein A chromatography purified IgG fraction

Pureté: > 90 %

Immunogène: SARS coronavirus antibody was raised in mouse using nucleoprotein of the SARS virus as the immunogen.

Isotype: IgG1

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Commentaires:

This SARS-CoV Nucleocapside antibody reacts with SARS-CoV protein (ABIN6952561).

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: 10 mM PBS, pH 7.4 with 0.1 % Sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: -20°C

Détail du antigène

Antigène: SARS-Coronavirus Nucleocapsid Protein (SARS-CoV N)

Autre désignation: SARS-Coronavirus Nucleocapsid Protein

Classe de substances: Viral Protein

Sujet: The SARS coronavirus, sometimes shortened to SARS-CoV, is the virus that causes severe acute respiratory syndrome (SARS). On April 16, 2003, following the outbreak of SARS in Asia and secondary cases elsewhere in the world, the World Health Organization (WHO) issued a press release stating that the coronavirus identified by a number of laboratories was the official cause of SARS. Samples of the virus are being held in laboratories in New York, San Francisco, Manila, Hong Kong, and Toronto.